Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
PH-6452 by PHAIT for Lung Cancer: Likelihood of Approval
PH-6452 is under clinical development by PHAIT and currently in Phase I for Lung Cancer. According to GlobalData, Phase I...
PH-7563 by PHAIT for Lung Cancer: Likelihood of Approval
PH-7563 is under clinical development by PHAIT and currently in Phase I for Lung Cancer. According to GlobalData, Phase I...
Iloprost by PHAIT for Lung Cancer: Likelihood of Approval
Iloprost is under clinical development by PHAIT and currently in Phase III for Lung Cancer. According to GlobalData, Phase III...